How Exposure to Environmental Tobacco Smoke, Outdoor Air Pollutants, and Increased Pollen Burdens Influences the Incidence of Asthma by Gilmour, M. Ian et al.
 
How Exposure to Environmental Tobacco Smoke, Outdoor Air
Pollutants, and Increased Pollen Burdens Influences the Incidence
of Asthma
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Gilmour, M. Ian, Maritta S. Jaakkola, Stephanie J. London, Andre
E. Nel, and Christine A. Rogers. 2006. How exposure to
environmental tobacco smoke, outdoor air pollutants, and
increased pollen burdens influences the incidence of asthma.
Environmental Health Perspectives 114(4): 627-633.
Published Version doi:10.1289/ehp.8380
Accessed February 18, 2015 11:38:27 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:4553296
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAAllergic diseases are the sixth leading cause of
chronic illness in the United States, affecting
17% of the population and costing the health
care system about $18 billion annually
[American Academy of Allergy, Asthma and
Immunology (AAAAI) 2000]. Approximately
40 million Americans suffer from allergic
rhinitis (hay fever), largely in response to com-
mon aeroallergens, resulting in 3.8 million lost
days of work and school [Centers for Disease
Control and Prevention (CDC) 2004].
Children with asthma are usually a subset of
allergic individuals with more respiratory
involvement characterized by chronic lung
inﬂammation, airway hyperreactivity (AHR),
and reversible airflow obstruction, whereas
new asthma in adults may be more often non-
allergic in nature [e.g., exercise-induced asthma
(AAAAI 2000) and irritant-induced asthma
(Tarlo 2003)]. Asthma commonly begins in
childhood, but can also start in adulthood, and
frequently requires doctor visits, long-term
medication use, and in some cases hospitaliza-
tions. Currently, the CDC estimates the preva-
lence of asthma in the U.S. adult population to
be 7.5% (16 million; CDC 2004).
Asthma and allergies have a strong heredi-
tary and hence genetic component that likely
works by modifying responses to ubiquitous
environmental exposures. The factors affecting
the onset of allergies and asthma are complex,
and considerable attention has focused on the
indoor environment [Institute of Medicine
(IOM) 2000], as well as outdoor pollutant
exposures (Peden 2003). Cigarette smoke and
diesel exhaust particles (DEPs), in particular,
have been shown to act synergistically with
allergen exposure to enhance the severity of
immune-mediated lung disease [California
Environmental Protection Agency (California
EPA) 1997; Diaz-Sanchez et al. 1997), and
new evidence shows that ozone exposure and
proximity to major roadways are associated
with increased incidence of disease (Diaz-
Sanchez et al. 2003; Heinrich and Wichmann
2004). In this review we illustrate how envi-
ronmental tobacco smoke (ETS), outdoor air
pollution, and climate change may act as envi-
ronmental risk factors for the development of
asthma and provide mechanistic explanations
for how some of these effects can occur.
Environmental Tobacco Smoke
Exposure to ETS—or passive smoking or
exposure to secondhand smoke—is deﬁned as
exposure of a (nonsmoking) person to tobacco
combustion products from smoking by others
(Jaakkola and Jaakkola 1997). The fetus can be
exposed either by the mother’s active smoking
or by her exposure to ETS during pregnancy.
The harmful substances of tobacco are then
transferred across the placenta to the fetus.
Tobacco smoke contains more than
4,000 chemical substances, many of which are
carcinogenic, mutagenic, irritating, or toxic.
Exposure to ETS can be assessed by measur-
ing air nicotine or respirable suspended parti-
cle concentrations with personal or stationary
monitors (Jaakkola and Jaakkola 1997).
Questionnaires are commonly used for assess-
ing ETS exposure in health effects studies
because they are relatively cheap and allow
exposure assessment during different time
periods and in different indoor environments.
In addition, biomarkers can be measured as
proxies for dose, including cotinine in body
ﬂuids and hair nicotine. Studies conducted in
the United States and Europe have detected
cotinine in urine as an indicator of passive
smoking in > 80% of the nonsmoking popu-
lations (Pirkle et al. 1996; Riboli et al. 1990;
reviewed by Jaakkola 2000). Questionnaire-
based assessment of ETS exposure has varied
from 7% in Finnish children (Jaakkola et al.
1994) to > 60% among Californian young
adults (California EPA 1997).
We chose ETS as a model indoor pollu-
tant in this review because at least some degree
of exposure to ETS is very common world-
wide, and studies have demonstrated that
nonsmokers are exposed to concentrations
high enough to be measured using biomarkers
such as cotinine in body fluids. In addition,
ETS contains several compounds that could
plausibly cause health effects. For example,
nicotine induces placental vasoconstriction,
which leads to hypoxia of the fetus and conse-
quently impaired maturation of the lungs.
Irritant substances in ETS may induce chronic
inﬂammation in the airways that could lead to
a form of irritant-induced asthma (Tarlo
2003). In addition, animal studies and even
some studies in children have suggested that
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Asthma is a multifactorial airway disease that arises from a relatively common genetic background
interphased with exposures to allergens and airborne irritants. The rapid rise in asthma over the past
three decades in Western societies has been attributed to numerous diverse factors, including
increased awareness of the disease, altered lifestyle and activity patterns, and ill-deﬁned changes in
environmental exposures. It is well accepted that persons with asthma are more sensitive than per-
sons without asthma to air pollutants such as cigarette smoke, trafﬁc emissions, and photochemical
smog components. It has also been demonstrated that exposure to a mix of allergens and irritants
can at times promote the development phase (induction) of the disease. Experimental evidence sug-
gests that complex organic molecules from diesel exhaust may act as allergic adjuvants through the
production of oxidative stress in airway cells. It also seems that climate change is increasing the
abundance of aeroallergens such as pollen, which may result in greater incidence or severity of aller-
gic diseases. In this review we illustrate how environmental tobacco smoke, outdoor air pollution,
and climate change may act as environmental risk factors for the development of asthma and provide
mechanistic explanations for how some of these effects can occur. Key words: air pollution, asthma,
cigarette smoke, climate change, diesel exhaust, environment, inﬂammation, mechanisms, ozone,
particulate matter, pollen. Environ Health Perspect 114:627–633 (2006). doi:10.1289/ehp.8380
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hypersensitivity reactions to allergens are
stronger. Indeed, based on the current knowl-
edge, ETS is likely to be the most important
indoor pollutant that is harmful for human
health. The literature for this review on ETS
and asthma is based on a Medline database
(http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db=PubMed&itool=toolbar) search up to
May 2004, but because of space constrictions,
we reference previous reviews when possible
and describe in detail only some recent longi-
tudinal or incident case–control studies.
ETS and induction of asthma in children.
Since the 1980s, numerous large studies have
identified significant relations between
parental smoking and development of asthma
in children (Cook and Strachan 1997, 1998;
Jaakkola 2000; J.J.K. Jaakkola and Jaakkola
2002). Meta-analyses based on these studies
have shown a dose-dependent increase in chil-
dren’s rates of asthma related to increasing
number of household smokers (Cook and
Strachan 1997), with the strongest effect
detected in the youngest children (California
EPA 1997; Strachan and Cook 1997, 1998).
Maternal smoking has been reported to have
a stronger effect than other household mem-
bers’ smoking, raising concern of the poten-
tial role of prenatal tobacco smoke exposure.
Recent studies have addressed the role of pre-
natal versus postnatal exposure. A cohort
study of 499 children of atopic parents from
Boston found that maternal smoking during
pregnancy was associated with an increased
risk of asthma in the ﬁrst year of life, with an
odds ratio (OR) of 1.83 [95% confidence
interval (CI), 1.12–3.00; Gold et al. 1999].
In a study based on the Finnish birth cohort
that included almost 60,000 children, the risk
of developing asthma among children 7 years
of age increased in a dose-dependent pattern
with the mothers’ smoking rates in preg-
nancy: OR 1.25 (95% CI, 1.09–1.44) for
< 10 cigarettes/day and 1.36 (1.14–1.63) for
> 10 cigarettes/day (Jaakkola and Gissler
2004). Signiﬁcant associations persisted even
after adjustment was made for low birth
weight and duration of pregnancy, suggesting
that the effect of passive smoking on asthma
was independent of these factors.
ETS and induction of asthma in adults.
Fewer studies have been published on ETS
exposure and asthma in adults. To date one
longitudinal, three case–control and at least six
cross-sectional studies have reported associa-
tions between ETS exposure and adult-onset
asthma, with ORs between 1.15 and 3.30
[reviewed by Jaakkola (2000) and by M.S.
Jaakkola and Jaakkola (2002)]. In many studies
the risk of asthma was more strongly related to
workplace ETS exposure than to home expo-
sure, and several studies showed evidence of a
dose–response relation. A problem with most
studies was that they included existing (preva-
lent) cases of asthma, making it impossible to
distinguish development of asthma in adult-
hood from exacerbation of established disease.
Another methodologic issue was the reliance on
questionnaire reports of asthmatic symptoms or
diagnosed asthma, as it may be difﬁcult to dis-
tinguish between asthma and chronic obstruc-
tive pulmonary disease without clinical
investigations. To address these challenges
Jaakola et al. (2003) conducted a population-
based case–control study with incident cases of
asthma. The study assessed the effect of ETS
exposure on adult-onset asthma and estimated
the fraction of asthma attributable to ETS
exposure in the past year. All new clinically
diagnosed cases of asthma in individuals
21–63 years of age were recruited from 1997 to
2000 in a geographically deﬁned area in south-
ern Finland through all health care facilities
diagnosing asthma in this area. A random sam-
ple of the source population (residents of the
Pirkanmaa Hospital district, 21–63 years of
age) was recruited as controls. A total of
521 asthma cases and 932 controls without
asthma participated, including 239 persons
with asthma and 487 controls who were never-
smokers. These never-smokers formed the
study population for the analysis on ETS expo-
sure. Exposure to ETS was assessed on the basis
of a self-administered questionnaire. Table 1
shows the results of ORs for asthma related to
ETS exposure after adjusting for confounders
including gender, age, education, parental
atopy, and other occupational exposures in
multivariate logistic regression. ETS exposure at
work during the past 12 months was related to
a significantly increased risk of adult-onset
asthma, with an excess risk of 116% (95% CI,
26–272). Home exposure was associated with
an even higher risk, but the CI range for this
OR was wide because of a small number of
study subjects being exposed at home (Table 1).
Assessment of exposure quantitatively as cumu-
lative exposure combining home and workplace
exposures as cigarette-years suggested a
dose–response relation with the risk of asthma.
The fraction of exposed cases for which asthma
was attributable to ETS exposure in the past
year was 49% (95% CI, 16–69). The fraction
of all asthma cases in the working age popula-
tion (i.e., population-attributable fraction)
attributable to ETS exposure in the last year
was 8.0%.
Conclusions on ETS and possibilities for
prevention. Considering the number of stud-
ies, their validity, evidence of dose–response
relations, and biological plausibility, it can be
concluded that a) there is some evidence for
the effect of maternal smoking in pregnancy
on the risk of asthma in childhood; b) post-
natal exposure to ETS shows a causal link with
the development of asthma in childhood;
c) there is strong evidence that ETS is related
to an increased risk of adult-onset asthma; and
d) elimination or reduction of ETS exposure
could prevent a considerable fraction of
asthma in both children and adults.
Banning of smoking in the workplaces has
been shown to reduce employees’ exposure to
ETS and consequently fetal exposure of chil-
dren of working pregnant mothers. For exam-
ple, in Finland reformation of the tobacco
control law in 1995 to protect employees from
workplace ETS exposure led to a dramatic
decline in tobacco smoke exposure at work in
a 4-year follow-up of nine large- or medium-
sized workplaces in southern Finland (Table 2;
Heloma and Jaakkola 2003). This study also
showed a decline in active smoking during the
follow-up, suggesting that the legislation was
able to affect home ETS exposure as well.
To reduce childhood exposure, parents
should be educated and encouraged not to
smoke, or if they already are smokers, to quit,
through support in family planning and pre-
natal health care and at schools. Based on stud-
ies from Finland (Jaakkola et al. 1994, 2001)
and elsewhere (Owen et al. 1998), intensive
support should be provided for certain groups
at high risk for smoking during pregnancy and
Gilmour et al.
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Table 1. Exposure to ETS among cases and controls and adjusted OR of adult-onset asthma in relation to
ETS exposure at home and at work.
ETS exposure Cases [n (%)] Controls [n (%)] OR 95% CI
Past 12 months
At work 34 (15.6) 41 (9.0) 2.16 1.26–3.72
At home 7 (3.0) 8 (1.7) 4.77 1.29–17.7
Cumulative cigarette-years (home and work)
0 104 (43.5) 231 (47.4) 1.00
1–49 26 (10.9) 91 (18.7) 0.80 0.48–1.36
50–99 22 (9.2) 44 (9.0) 1.30 0.71–2.35
100–149 19 (8.0) 25 (5.1) 2.01 1.02–3.99
≥ 150 68 (28.5) 96 (19.7) 1.84 1.21–2.80
Adapted from Jaakkola et al. (2003).
Table 2. ETS exposure (%) in nine large- or medium-
sized workplaces before and after 1995 reformation
of the national tobacco control legislation in Finland.
Daily ETS 1994–1995 1995–1996 1998
exposure at work (n = 605) (n = 681) (n = 474)
Not at all 20.7 54.2 70.7
< 1 hr 28.8 28.6 17.5
1–4 hr 17.7 9.0 8.4
> 4 hr 32.9 8.2 3.4
Adapted from Heloma and Jaakkola (2003).after delivery, such as young, single mothers
with limited education. It has been suggested
that effective secondary prevention could take
place during doctor visits due to child’s respira-
tory problems. The most important issue for
future research is how to eliminate (or at least
reduce) ETS exposure effectively both in child-
hood and adulthood.
Ambient Air Pollution and
Asthma Induction
Although extensive evidence shows that
ambient air pollution exacerbates existing
asthma, a link with the development of asthma
is less well established. This is primarily
because few prospective studies with extensive
exposure data have been conducted. However,
in the past few years, some limited data sets
have emerged to support associations between
air pollution and incidence of asthma. The
ambient air pollutants studied have included
particulate matter (PM), nitrogen dioxide
(NO2), sulfur dioxide (SO2), and ozone (O3).
The epidemiologic data on whether ambi-
ent air pollution contributes to the incidence of
asthma are from ﬁve studies—three in children
and two in adults. Of the childhood studies,
one was a birth cohort from the Netherlands,
the Prevention and Incidence of Asthma and
Mite Allergy (PIAMA) study (Brauer et al.
2002), in which > 4,000 children were enrolled
at birth and followed up to 2 years of age.
Trafﬁc-related air pollution was assessed on the
basis of geographic information system models
that were validated by a network of 40 moni-
toring stations at which NO2, PM2.5 (PM with
aerodynamic diameter ≤ 2.5 µm), and
reﬂectance measures for “soot” were assessed at
four 2-week periods throughout a calendar
year. The outcomes were parental reports of
several phenotypes relevant to asthma; doctor-
diagnosed asthma, bronchitis, ENT (ear, nose,
and throat) infections, serious colds, or ﬂu; and
symptoms of wheeze and dry night cough.
Small but statistically signiﬁcant associations
[relative risk (RR), 1.11–1.20] were found
between traffic-related air pollution and
wheeze, doctor-diagnosed asthma, ENT infec-
tions, and serious colds or ﬂu.
An international collaborative study
involving the Netherlands, Germany, and
Sweden was established to examine traffic-
related air pollution and childhood asthma
(Gehring et al. 2002). Preliminary results pub-
lished for 1,756 infants in Germany with fol-
low-up through 2 years of age showed
signiﬁcant associations between dry cough at
night in the ﬁrst year of life and three meas-
ures of pollution—NO2, PM2.5, and soot,
with ORs of 1.32–1.40. The associations
persisted but were weaker in the second year
of life (ORs 1.16–1.24). No association was
found with wheezing, respiratory infections,
or bronchitis.
The Children’s Health Study (CHS)
includes > 6,000 children enrolled in 1993
and 1996 in 12 communities throughout
southern California and provides a maximum
range in exposure to ambient ozone, particles,
acids, and oxides of nitrogen (McConnell
et al. 2002). This report included 3,535 chil-
dren without asthma at baseline and at least
1 year of follow-up during which 259 new
cases of asthma diagnosis were reported. Air
pollution was defined in this analysis by
whether the community in which the child
lived was in the bottom or top half of expo-
sure for a given pollutant. The communities
divided the same way for PM, NO2, and
acids, but the high- and low-ozone communi-
ties were different. When ozone levels were
examined alone, there was no increased risk of
asthma with high exposure, and the peak level
was actually related to significantly dimin-
ished risk. When children who participated in
sports activities were examined, those who
played three or more sports had an increased
risk of asthma (RR = 1.8; 95% CI, 1.2–2.8).
When the sports variable was further stratiﬁed
by high/low air pollution status, there was no
difference for particles, NO2, or acids, but an
effect of three or more sports was strongly
seen in the high-ozone communities. It
should be noted that this finding was based
on taking a very small category and dividing it
into two subsets; only 9 of the 29 cases were
in the low-ozone communities (RR = 0.8),
versus 20 in the high-ozone communities
(RR = 3.3; 95% CI, 1.9–5.8).
The evidence on air pollution and asthma
incidence in adults comes from a cohort study
of Seventh-day Adventists in California,
known as the ASHMOG study. Investigators
analyzed air pollution exposure in residentially
stable nonsmokers in 1977 and followed up in
1982 and 1992. Exposure was based on the
nearest monitoring station to the work and
home addresses. In the ﬁrst study, Abbey et al.
(1995) examined incident asthma (79 cases) in
relation to PM and reported a relative risk of
1.30 (95% CI, 0.97–1.73) for 1,000 hr/year
exposure to concentrations of PM10 (PM 
with aerodynamic diameter ≤ 10 µm) that
exceeded 100 µm/m3. A later study on ozone
that included 115 incident cases of asthma
(McDonnell et al. 1999) reported an increased
risk in men for a 27 ppb (interquartile range)
increase in ozone (RR = 2.09; 95% CI,
1.03–4.16) but no association in women.
In summary the results from the five
prospective studies support a modest increase
in risk for air pollution in relation to pheno-
types relevant to asthma. The three studies of
subjects old enough to have a ﬁrm diagnosis
of asthma share limitations of uncertainty
about when asthma started. This is a caveat
for any prospective study of chronic disease,
however, where it is difficult to distinguish
possible exacerbation of preclinical symptoms
from incidence of new asthma. The children’s
studies are still quite small in scope, and activ-
ity patterns such as number of outdoor sports
may also reﬂect other unrealized confounders.
Numerous large-scale initiatives [e.g., the
National Children’s Study (NCS 2005)]
designed to track disease incidence and sever-
ity from before birth and relate those effects
to environmental exposures will be able to
more clearly deﬁne risk factors for the devel-
opment of diseases such as asthma.
Role of Prooxidative DEP
Chemicals in Airway
Inﬂammation and 
Allergic Adjuvancy
Four key questions [National Research
Council (NRC) 1998) regarding the adverse
health effects of PM on asthma are a) What is
the mechanism by which PM affects car-
diorespiratory morbidity and mortality?
b) What are the PM components responsible
for adverse health effects? c) What are the
types and sizes of PM that are most potent?
and d) Who in the population is more prone
to adverse health effects? The impact of PM
on the genesis and exacerbation of asthma is a
good disease model to probe these questions
(Nel et al. 1998). Atopic asthma is a disease
of allergic airway inflammation, which from
an ambient particle perspective could be
approached by studying how PM pollutants
in combination with common aeroallergens
lead to a) the genesis of asthma, b) T-helper 2
(TH2) immune deviation by acting as adju-
vants for allergic inflammation, and c) acute
exacerbation of existing disease through an
effect on AHR (Li et al. 2003a, 2003b).
To approach the questions listed above
from an investigative perspective, reseachers
have used DEPs as a model PM pollutant for
in vitro and in vivo experiments (Nel et al.
1998). Several groups have demonstrated that
DEPs can act as an adjuvant when combined
with an experimental allergen, ovalbumin,
resulting in enhanced IgE antibody produc-
tion and increased allergic inﬂammation and
AHR in mice (Miyabara et al. 1998; Whitekus
et al. 2002; Xiao et al. 2003). To define the
mechanistic basis for the proinflammatory
effects of DEPs, Li et al. (2000, 2004)
approached the problem from the premise
that DEPs contain a large number of chemi-
cals that play a role in inflammation. This
includes transition metals as well as a host of
organic chemical compounds. Among the
organic chemicals, there is good evidence for
the role of polycyclic aromatic hydrocarbons
(PAHs) and quinones as toxicologically rele-
vant compounds that give rise to reactive
oxygen species (ROS) (Li et al. 2003a, 2003b;
Monks et al. 1992; Penning et al. 1999; Xia
Environmental exposures and asthma
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used to fractionate organic DEP extracts into
aliphatic, aromatic, and polar compounds,
which were enriched for N-alkenes, PAHs,
and quinones, respectively (Alsberg et al.
1985; Li et al. 2000, 2004). Among these, the
polar compounds are the most potent in par-
ticipating in redox cycling reactions as deter-
mined by the interactions with the thiol
derivative dithiothreitol (DTT). There is an
excellent correlation between the results of the
DTT assay and the ability of the various DEP
fractions to induce oxidative stress in tissue
culture macrophages and epithelial cells (Li
et al. 2000, 2003b, 2004). Moreover, the
same chemical groups are present in ETS,
which may contribute to allergic airway
inﬂammation in a fashion similar to DEPs.
Although ROS is generally accepted as
playing a role in asthma, demonstration of this
in animals and humans involves mostly in-
direct evidence from blood, bronchoalveolar
lavage ﬂuid, and exhaled air samples. Although
direct measurement of ROS production in the
respiratory tract is difﬁcult, it is possible to use
the biological impact of ROS generation in
studying the effect of these radicals. When the
production of ROS exceeds the ability of the
affected tissue to neutralize the effects of the
radicals, depletion in intracellular glutathione
can result in a state of oxidative stress (Li et al.
2003a, 2003b). To develop new biomarkers
for oxidative stress, several research groups
used a proteomics display of newly induced
oxidative stress proteins or posttranslationally
modiﬁed proteins in PM target cell types such
as macrophages and epithelial cells (Wang
et al. 2005; Xiao et al. 2003, 2005) Upon
exposure to prooxidative organic chemical
components from DEPs, these cells show
three tiers of oxidative stress, which are predic-
tive of a possible in vivo hierarchical oxidative
stress response (Figure 1) (Li et al. 2003a; Xiao
et al. 2003). This model posits that as the level
of oxidative stress increases, there is a transition
from protective to injurious effects. Not only
do these biological outcomes provide possible
biomarkers of oxidative stress, but this model
could also provide clues about susceptible
human subjects.
In the ﬁrst tier of oxidative stress, epithe-
lial cells and macrophages respond by increas-
ing expression of antioxidant and phase II
enzymes (e.g., superoxide dismutase, catalase,
glutathione peroxidase, glutathione reductase,
γ-glutamate cysteine ligase, glutathione
S-transferase, NADPH quinone oxidoreduc-
tase, heme oxygenase 1) via a genetic response
pathway that acquires transcriptional activa-
tion of the antioxidant response element
(ARE) by the transcription factor nuclear
regulatory factor 2 (Nrf2) (Li et al. 2004). The
Nrf2–ARE pathway protects against the inju-
rious and proinﬂammatory effects of PM, and
it has been proposed that a weakening of
antioxidant defense (e.g., by the polymor-
phism of these genes) could determine which
human subsets are susceptible to PM effects
(Fryer et al. 2000). This notion is supported
by recent data showing an increased asthma
frequency in people with a polymorphism in
the glutathione S-transferase who are more
prone to increased IgE production in response
to an intranasal co-challenge with allergen and
DEPs (Gilliland et al. 2004). Similarly, there
is evidence in animal asthma models that over-
expression of heme oxygenase 1, a phase II
enzyme with potent antioxidant effects, leads
to a blunting of AHR and airway inﬂamma-
tion (Hisada et al. 2000).
In the second tier of oxidative stress, the
activation of several intracellular signaling cas-
cades could lead to transcriptional activation of
proinflammatory genes (Xiao et al. 2003).
Phosphoproteome analysis and anti-phospho-
peptide immunoblotting demonstrate the acti-
vation of three major mitogen-activated protein
(MAP) kinase cascades in epithelial cells and
macrophages by DEPs, crude DEP extracts,
and aromatic and polar DEP fractions (Wang
et al. 2005; Xiao et al. 2003). Activation of
these pathways leads to tumor necrosis factor-α,
interleukin (IL)-8, IL-6, and vascular endothe-
lial growth factor production that could be
inhibited by MAP kinase inhibitors (Wang
et al. 2005). It is noteworthy that the induction
of AHR and airway inflammation can be
blocked in a murine asthma model by employ-
ing a small-molecule inhibitor that interferes in
the transcriptional activity of AP-1 (activator
protein 1) proteins. There is good evidence that
the above cytokines and chemokines affect air-
way inflammation and asthma, thereby con-
tributing to the effects of the classical TH2
cytokines such as IL-4, IL-5, and IL-13. Nasal
challenge studies with DEPs demonstrated that
PM enhances TH2 cytokine production in
atopic people during co-challenge with an aller-
gen. These cytokine effects could form the basis
for the adjuvant effects of DEPs on allergic
inﬂammation in addition to the possibility that
these particles affect the function of antigen
presenting cells (Nel et al. 1998).
The third tier of oxidative stress involves
mitochondrial perturbation, which can lead to
apoptosis, apoptosis–necrosis, and superoxide
generation (Hiura et al. 1999). In this regard, it
is relevant that ambient ultraﬁne PM (PM <
0.1 µm) lodges in and induces structural dam-
age in mitochondria (Li et al. 2003b). Although
the clinical relevance of mitochondrial damage
is uncertain, it is relevant that ultraﬁne PM col-
lected in the Los Angeles basin has a higher
content of redox-cycling organic compounds
that are more prone to generate ROS in the
DTT assay than does PM2.5 and PM10 (Li et al.
2003b). DEPs contribute signiﬁcantly to the
ultraﬁne PM load in an urban area. Although
there is ample epidemiologic evidence that
PM10 and PM2.5 play a role in asthma, there is
a paucity of data on the role of ultraﬁne PM in
asthma. However, on the basis of their small
size, large surface area, high numbers, rich con-
tent of redox cycling chemicals, and high depo-
sition efficiency, ultrafine PM may be
particularly prone to induce airway inﬂamma-
tion and AHR (Penttinen et al. 2001). Since
vehicular emissions have a signiﬁcant output of
ultraﬁne particles, it is relevant, therefore, that a
number of studies have shown a link between
trafﬁc density and asthma exacerbation in inner
city populations (Brauer et al. 2002).
In summary, there is growing evidence that
PM-induced oxidative stress may be responsi-
ble for generating airway inflammation and
AHR that are both markers and possibly pre-
cursors for the development of asthma. In
addition, there is the realization that not all
oxidative stress responses are injurious but also
include a protective lower level of oxidative
stress (tier 1 response; Figure 1) that could
form the basis of disease susceptibility.
Impact of Global Warming 
and Climate Change 
on Aeroallergens
Climate and allergen load. It is generally
thought that for atopic asthma or allergic dis-
ease to develop, both genetic predisposition
and allergen exposure are required. Therefore,
it is important to understand how impending
climate change will affect the aeroallergens that
elicit disease onset and precipitate symptoms.
Gilmour et al.
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Figure 1. Hierarchical oxidative stress model in
response to DEP exposure: proteome analysis of
oxidative stress proteins shows a hierarchical
response. Incremental doses of organic DEP
extracts induce a series of incremental cellular
responses that include increased antioxidant
offense, inﬂammation, and cytotoxicity. At a lower
level of oxidative stress (tier 1), antioxidant enzymes
are induced to restore cellular redox homeostasis.
At an intermediate level of oxidative stress (tier 2),
newly expressed proteins often exhibit proinflam-
matory activity. At a high level of oxidative stress
(tier 3), perturbation of the mitochondrial permeabil-
ity transition pore and disruption of electron trans-
fer result in cellular apoptosis or necrosis.
Abbreviations: FADD, Fas-associating protein with death
domain; GM-CSF, granulocyte-macrophage colony-stimu-
lating factor; iNOS, inducible nitric oxide synthase; SOD,
superoxide dismutase; TNF, tumor necrosis factor;
VDAC-1, voltage-dependent anion channel 1.
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Cell responseClimate warming that has occurred over recent
decades (about 0.6°C thus far) has dramatically
advanced budburst in spring (Fitter and Fitter
2002), therefore bringing forward the aller-
genic pollen season for spring-flowering 
taxa (Figure 2) (Rasmussen 2002; van Vliet
et al. 2002). The rate of these advances
(0.84–0.9 days/year) (Clot 2003; Frenguelli
et al. 2002) provides some of the best evidence
of the current impacts of recent climate change.
The most predictable climate changes over
the next century involve an approximate dou-
bling of atmospheric carbon dioxide (CO2)
and a rise in average global temperature within
the range of 1.4–5.8°C [Intergovernmental
Panel on Climate Change (IPCC) 2001].
Numerous studies on plant responses to ele-
vated CO2 indicate that plants will exhibit
enhanced photosynthesis, biomass production,
water use efficiency, and reproductive effort
(Bazzaz 1990; Drake et al. 1997; Jablonski
et al. 2002; LaDeau and Clark 2001; Stiling
et al. 2004). These are considered positive
developments for agriculture, but for allergic
individuals they could augur increased exposure
to airborne pollen. Some studies have in fact
shown increased pollen production under con-
ditions of elevated CO2. Ragweed (Ambrosia
artemisiifolia) is a weed of open disturbed
ground that produces potent pollen allergens.
In controlled environment experiments, plants
grown at elevated CO2 had greater biomass
and produced 61–90% more pollen (Wayne
et al. 2002; Ziska and Caufield 2000).
Temperature and CO2 can also have interac-
tive effects on pollen production. In experi-
ments simulating early spring release from
dormancy, ragweed plants grew larger, had
more inflorescences, and produced more
pollen than did later cohorts. Early cohorts
under high levels of CO2 produced the same
amount of pollen as those under ambient
CO2, but later cohorts at high CO2 differed
by producing 55% more pollen than their
ambient CO2 counterparts (Rogers et al.
2006). Long-term records at pollen-monitor-
ing stations in Europe show increasing annual
totals for other types, including hazel, birch,
and grass (Frei 1998; Spieksma 1995). Finally,
a likely result of climate change will be shifts
in the distributions of taxa as some species will
be able to take advantage of new conditions,
whereas others will not (Ziska 2003). For
example, droughts may create open habitat
that ragweed can colonize and therefore
expand the range of this invasive and highly
allergenic species in Europe resulting in indi-
viduals being exposed to new allergens.
CO2, climate, and molds. There is little
evidence of the effects of climate change on
fungal growth and reproduction, although the
implications for allergic disease are just as
important. As it is for pollen, exposure to fun-
gal spores is unequivocally associated with exac-
erbations of allergy and asthma (IOM 2000).
Long-term ﬁeld experiments with elevated CO2
show that some fungi in mycorrhizal associa-
tions with trees have enhanced growth and
sporulation (Klironomos et al. 1997; Treseder
et al. 2003; Wolf et al. 2003). Although more
evidence is needed to establish the certainty of
these effects for a wider range of fungi over a
gradual increase in CO2 (Klironomos et al.
2005), plausible arguments can be made for the
likelihood of increased fungal biomass (and
resulting sporulation) under climate change sce-
narios that would include increases in both
mycorrhizal fungi to facilitate enhanced plant
growth and saprobic fungi to degrade the
increased plant biomass generated.
Fungi are also an important factor in
indoor exposures leading to allergic and asth-
matic events (Jaakkola and Jaakkola 2004).
Several studies have shown that home damp-
ness is a significant predictor of respiratory
symptoms (Bornehag et al. 2001; Dales et al.
1991; IOM 2004). In a warmer climate,
increased and more widespread reliance on air
conditioning will occur, and the inevitable mis-
management of building ventilation will likely
result in more cases of inappropriate moisture
conditions in buildings. Changes in precipita-
tion regimes are also anticipated, with heavier
downpours and more widespread flooding.
Increased ﬂooding in coastal areas is projected
with increases in sea level. All of these scenarios
indicate a higher likelihood of wet interior sur-
faces that are prone to fungal growth. Inequities
are likely to occur as lower-income families are
less able to cope with expensive remediation or
ﬂood insurance (if available).
In summary, projected changes in climate
over the next century will inﬂuence plant and
fungal reproductive responses and alter the
timing, production, and distribution of
aeroallergens. Increased allergen exposures as
a result of global warming, in combination
with pollutant exposures such as DEPs that
can act synergistically to enhance the allergic
response, could mean increased respiratory
difﬁculties in the years ahead.
Summary of Key Issues
The increasing asthma incidence worldwide is
a complex issue that is not well understood.
There are more cars and trucks on the road
now than ever before, and half the U.S. popu-
lation lives and works in areas out of compli-
ance with U.S. EPA standards for ozone or
PM2.5 (Figure 3). There is compelling evi-
dence that exposure to ETS increases the risk
of asthma in both children and adults, and
although not conclusive, some prospective
studies are showing small but statistically sig-
niﬁcant associations between air pollution and
the incidence of asthma. In addition, increased
temperature and CO2 due to climate change
likely will result in increased production of
pollen and fungal spores that could exacerbate
symptoms of allergic diseases. More climatic
and population studies linking chemical expo-
sures, genetic susceptibility, daily activity pat-
terns, dietary factors, and preexisting disease
are needed to understand and quantify the
associations between environmental factors
Environmental exposures and asthma
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Figure 2. Peak date of airborne birch (Betula) pollen concentrations in Denmark, 1978–1999. Viborg: Ym =
122.1; β = –0.67; r = –0.81; p < 0.001. Copenhagen: Ym = 123.3; β = –0.74; r = –0.92; p < 0.001. Adapted from
Rasmussen (2002).
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Figure 3. Number of people living in counties with
air quality levels above the National Ambient Air
Quality Standards (NAAQS) in 2000. Abbreviations:
CO, carbon monoxide; Pb, lead. Data from U.S. EPA
(2005).Gilmour et al.
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and the development of asthma. In parallel,
toxicologic studies can identify the role that
particular chemicals such as diesel exhaust
components and ozone play in the develop-
ment and exacerbation of disease. In the short
term such studies may help to determine how
individuals can be protected, whereas in the
long term they may provide useful informa-
tion to establish limits for release of these
chemicals to safe acceptable levels.
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